CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AbbVie Inc. v. Hikma Pharmaceutical Co Ltd.

1:13-cv-01557

Overview

Case Number 1:13-cv-01557
Filing Date 2013-09-13
Status Terminated
Termination Date 2014-03-20
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Hikma Pharmaceutical Co Ltd. Operating Company

Represented By

3 Attorneys Listed

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 661-7394

The Nemours Building, 1007 North Orange Street, Suite 1200

Jeffrey S. Ward

Email: jward@nge.com

Wendy M. Ward

Email: wward@merchantgould.com

West-Ward Pharmaceuticals Corp. Operating Company

Represented By

1 Attorneys Listed

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 661-7394

The Nemours Building, 1007 North Orange Street, Suite 1200

Exela Pharma Sciences LLC Operating Company

Represented By

1 Attorneys Listed

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 661-7394

The Nemours Building, 1007 North Orange Street, Suite 1200

AbbVie Inc. Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Defendant

Wisconsin Alumni Research Foundation NPE (University / Research)

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): πŸ‡¨πŸ‡¦ Canada πŸ‡©πŸ‡ͺ Germany πŸ‡ͺπŸ‡Ί Europe πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5597815
Prevention of hyperphosphatemia in kidney disorder patients
Filed: 1995-07-13
Issued: 1997-01-28
Expired (Term Ended)
Expires: 2015-07-13

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

15

Dispositive

15

Granted

0

Denied

0

Pending / Review

6

Motions by Category

Motion to Dismiss 15

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
[SEALED] Joint STIPULATION TO EXTEND TIME to Respond to Motion to Dismiss to January 27, 2014 (Plaintiffs' opposition) and February 14, 2014 (Defendants' reply)...
Entry #11 • 2014-01-02 Document →
Motion to Dismiss Pending / Under Review
[SEALED] Joint STIPULATION TO EXTEND TIME to submit Plaintiffs' Opposition regarding Motion to Dismiss; and to submit Defendants' Reply regarding Motion to Dism...
Entry #10 • 2013-11-20 Document →
Motion to Dismiss Pending / Under Review
Joint STIPULATION TO EXTEND TIME to submit Plaintiffs' opposition to [D.I. 5] Motion to Dismiss, and for Defendants' to submit their reply to Plaintiffs' opposi...
Entry #9 • 2013-10-30 Document →
Motion to Dismiss Pending / Under Review
MOTION to Dismiss Based upon Improper Orange Book Listing - filed by Exela Pharma Sciences LLC, Hikma Pharmaceutical Co Ltd., West-Ward Pharmaceuticals Corp.. (...
Entry #5 • 2013-10-25 Document →
Motion to Dismiss Pending / Under Review
MEMORANDUM in Support re 5 MOTION to Dismiss Based upon Improper Orange Book Listing filed by Exela Pharma Sciences LLC, Hikma Pharmaceutical Co Ltd., West-Ward...
Entry #6 • 2013-10-25 Document →
Motion to Dismiss Pending
DECLARATION re 6 MEMORANDUM in Support, 5 MOTION to Dismiss Based upon Improper Orange Book Listing - Declaration of Wendy Ward in Support of Defendants' Motion...
Entry #7 • 2013-10-25 Document →

Docket Entries

(27 total)
Pleading / Complaint

COMPLAINT filed against Exela Pharma Sciences LLC, Hikma Pharmaceutical Co Ltd., West-Ward Pharmaceuticals Corp. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1367467.) - filed by Wisconsin Alumni Research Foundation, AbbVie Inc.. (Attachments: # 1 Exhibit A and B, # 2 Civil Cover Sheet)(els) (Entered: 09/16/2013)

Entry #1 • 2013-09-13
1
Pleading / Complaint

COMPLAINT filed against Exela Pharma Sciences LLC, Hikma Pharmaceutical Co Ltd., West-Ward Pharmaceuticals Corp. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1367467.) - filed by Wisconsin Alumni Research Foundation, AbbVie Inc.. (Attachments: # 1 Exhibit A and B, # 2 Civil Cover Sheet)(els) (Entered: 09/16/2013)

Entry #1 • 2013-09-13
2
Pleading / Complaint

COMPLAINT filed against Exela Pharma Sciences LLC, Hikma Pharmaceutical Co Ltd., West-Ward Pharmaceuticals Corp. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1367467.) - filed by Wisconsin Alumni Research Foundation, AbbVie Inc.. (Attachments: # 1 Exhibit A and B, # 2 Civil Cover Sheet)(els) (Entered: 09/16/2013)

Entry #1 • 2013-09-13
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els) (Entered: 09/16/2013)

Entry #2 • 2013-09-13
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/31/13. Date of Expiration of Patent: 7/13/15.Thirty Month Stay Deadline: 1/31/2016. (els) (Entered: 09/16/2013)

Entry #3 • 2013-09-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc